MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Location
Founded
1989-12-19
Website
Risk Signals
4960 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Surgical and Medical Instruments and Apparatus, Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about MEDTRONIC VASCULAR GALWAY UNLIMITED COMPANY
Live alerts from global media, monitored by Business Radar
2025-01-10 (marketbeat.com)
Brett A. Wall Sells 9,850 Shares of Medtronic plc (NYSE:MDT) Stock
Medtronic plc (NYSE:MDT - Get Free Report) EVP Brett A. Wall sold 9,850 shares of Medtronic stock in a transaction dated Wednesday, January 8th. The shares were sold at an average price of $80.41, for a total value of $792,038.50. Following the completion of the sale, the executive vice president now directly owns 40,708 shares in the company, valued at $3,273,330.28. This represents a 19.48 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Read more
2024-11-27 (aktiencheck.de)
Medtronic shares: A clear winner! ()
Medtronic shares: A clear winner! () | aktiencheck.de
Read more
2024-11-23 (finmarket.ru)
Finam maintains Medtronic stock rating at "buy" level
Finam maintains a “buy” rating for Medtronic PLC shares with a target price of $101.8 per share, according to Zarina Saidova, a leading analyst at the stock analysis department.
Read more
2024-09-30 (aktiencheck.de)
Medtronic shares: stable price despite challenges ()
Medtronic shares: stable price despite challenges () | aktiencheck.de
Read more
2024-09-14 (sharewise.com)
3 Reasons Medtronic's Stock Can Continue Rallying Higher
Medtronic (NYSE: MDT) hasn't been a terribly hot stock to own in recent years. Since 2021, its shares have declined by more than 20%. But recently, investors do appear to have been giving the stock
Read more
2024-09-05 (finmarket.ru)
Finam maintains Medtronic stock rating at "buy" level
Finam maintains a buy rating on Medtronic PLC shares with a target price of $101.8 per share, which corresponds to a growth potential of 14.4%, according to Zarina Saidova, a leading analyst at the stock research department.
Read more
2024-09-01 (etfdailynews.com)
Medtronic plc (NYSE:MDT) Shares Acquired by Pinnacle Associates Ltd.
Pinnacle Associates Ltd. increased its holdings in shares of Medtronic plc (NYSE:MDT – Free Report) by 4.7% during the second quarter, HoldingsChannel.com reports. The fund owned 131,862 shares of the medical technology company’s stock after buying an additional 5,931 shares during the period.
Read more
2024-06-07 (massdevice.com)
Medtronic shares more positive Evolut TAVR data
Medtronic announced new data from its CoreValve Evolut clinical program supporting the transcatheter aortic valve replacement (TAVR) system.
Read more
2024-06-01 (finmarket.ru)
Finam assigns a "buy" rating to Medtronic shares
Finam assigned a “buy” rating to Medtronic PLC shares with a target price of $101.8 over a 12-month horizon, which corresponds to a growth potential of 24.9% from current levels, the investment company reported in its analytical material.
Read more
2024-02-08 (marketbeat.com)
Financiere des Professionnels Investment Funds Inc. Invests $5.28 Million in Medtronic plc (NYSE:MDT)
Financiere des Professionnels Fonds d investissement inc. acquired a new stake in shares of Medtronic plc (NYSE:MDT - Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm acquired 67,344 shares of the medic
Read more
2024-01-23 (sharewise.com)
Is Medtronic Stock a Buy Now?
Many stocks performed well last year, but Medtronic (NYSE: MDT) wasn
Read more
2024-01-20 (boerse-express.com)
Medtronic shares: Positive development despite challenges
Medtronic shares have been robust in recent months and have gained 6.32% over the past 12 months. Despite slight price fluctuations, the share is currently trading at USD 88.13, which corresponds to a decrease of 0.59% from the previous day.
Read more